Nasdaq smmt.

Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.Web

Nasdaq smmt. Things To Know About Nasdaq smmt.

Cambridge, Massachusetts, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying an important ePoster at IDWeek 2021.Nov 9, 2023 · During the recent session, Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares were 1.08 million, with the beta value of the company hitting -1.02. At the last check today, the stock’s price was $1.65, reflecting an intraday loss of -9.32% or -$0.18. The 52-week high for the SMMT share is $5. BABA. 73.60. -1.71%. 19.59M. New. View today's Summit Therapeutics PLC stock price and latest SMMT news and analysis. Create real-time notifications to follow any changes in the live stock price.WebSummit Therapeutics (NASDAQ: SMMT ) announced during its Third Quarter 2023 Earnings and Update Call that it has started enrolling for the second Phase III clinical trial for ivonescimab, a potential treatment for non-small cell lung cancer. The company also introduced its new Chief Operating Officer, Manmeet Soni, who has made a $5 million …WebCambridge, MA, July 12, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) is today displaying three preeminent ePosters at the prestigious 31st ...Web

In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, ...Research Summit Therapeutics' (Nasdaq:SMMT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance ...

Nasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 3.00% Before Hours...Dec 3, 2023 · Principal Financial Group Inc. purchased a new stake in shares of Summit Therapeutics Inc. (NASDAQ:SMMT – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 13,679 shares of the company’s stock, valued at approximately $34,000. A number of other […] Summit Therapeutics Inc (NASDAQ:SMMT) 1.93 Delayed Data As of Nov 17 +0.07 / +3.76% Today’s Change 0.66 Today ||| 52-Week Range 5.78 -54.59% Year-to-Date Quote Profile News Charts Forecasts...Cambridge, MA, May 17, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) today reports its financial results and provides an update on its operational progress for the first quarter ended March 31, 2021.Complete Summit Therapeutics Inc. stock information by Barron's. View real-time SMMT stock price and news, along with industry-best analysis.

Summit Therapeutics Inc. Common Stock (SMMT) 0 Add to Watchlist Add to Portfolio SMMT SMMT INSIDER ACTIVITY SMMT Insider Activity Number of Insider Trades Data is …

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK.

Nov 28, 2023 · Stock analysis for Summit Therapeutics Inc (SMMT:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Dec 4, 2023 · Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ... Cambridge, MA, June 01, 2022 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Ankur Dhingra has been appointed as Chief Financial Officer, effective immediately. “We are in a pivotal time for Team Summit as we seek to expand our portfolio of pipeline assets through potential collaborations and …Summit Therapeutics Inc (NASDAQ:SMMT) 1.93 Delayed Data As of Nov 17 +0.07 / +3.76% Today’s Change 0.66 Today ||| 52-Week Range 5.78 -54.59% Year-to-Date Quote Profile News Charts Forecasts...CAMBRIDGE, Mass. and OXFORD, United Kingdom, Sept. 11, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for ...WebAs part of this collaboration deal, Summit Therapeutics paid $500 million upfront (financed via a rights offering) and could be on the hook for another $4.5 billion in future milestone payouts ($1 ...

Nasdaq provides company’s , which are financial statements and reports filed electronically with the U.S. Securities and Exchange Commission (SEC) by Quotemedia. The SEC requires all publicly ...Oxford, UK, and Cambridge, MA, US, 18 September 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM) today announced the publication of a Personal Perspective entitled “Combating ...Oxford, UK, and Cambridge, MA, US, 14 April 2020 – Summit Therapeutics plc (NASDAQ: SMMT) today announces that Mr Robert (Bob) Duggan has been appointed Chief Executive Officer (‘CEO’) of ...Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.

Summit Therapeutics Inc. analyst ratings, historical stock prices, earnings estimates & actuals. SMMT updated stock price target summary.Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.

Phunware Inc (NASDAQ:PHUN)’s Major holders Insiders own 8.46% of the company shares, while shares held by institutions stand at 9.60% with a share float percentage of 10.48%. Investors are also buoyed by the number of investors in a company, with Phunware Inc having a total of 43 institutions that hold shares in the company.S&P 500 Nasdaq 100 Dow Jones Cryptocurrency Wallstreetbets Futures Earnings ... (SMMT) Sector: N/A Industry: N/A. $1.9500. -0.1400 (-6.70%). Post: $1.99 (2.05 ...OXFORD, United Kingdom, Oct. 25, 2017 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...WebOXFORD, United Kingdom, Sept. 18, 2015 (GLOBE NEWSWIRE) -- Summit (NASDAQ:SMMT) (AIM:SUMM), the drug discovery and development company advancing therapies for Duchenne Muscular Dystrophy and C ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.Summit Therapeutics Inc (NASDAQ:SMMT)’s traded shares stood at 0.38 million during the last session, with the company’s beta value hitting -1.00. At the close of trading, the stock’s price was $2.00, to imply an increase of 2.56% or $0.05 in intraday trading. The SMMT share’s 52-week high ...(SMMT). NASDAQ: SMMT · IEX Real-Time Price · USD. Add to Watchlist. 2.13. +0.10 (4.93%). Dec 1, 2023, 4:00 PM EST - Market closed. Overview · Financials ...Summit Therapeutics Inc (NASDAQ:SMMT)’s Major holders. Insiders own 29.61% of the company shares, while shares held by institutions stand at 3.27% with a share float percentage of 4.64%. Investors are also buoyed by the number of investors in a company, with Summit Therapeutics Inc having a total of 119 institutions that hold shares in the ...11 de mai. de 2023 ... (NASDAQ: SMMT) ("Summit," "we," or the "Company") today reports its financial results and provides an update on operational progress for the ...

Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California, and we have additional offices in Oxford, UK ...

Follow. Cambridge, MA, May 18, 2021 - Summit Therapeutics Inc. (NASDAQ: SMMT) announced today that it has selected a new preclinical candidate, SMT026738 (“SMT-738”), for development in the ...

Nov 3, 2021 · Follow. Cambridge, Massachusetts, Nov. 03, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that Dr. Urte Gayko, PhD, has been appointed to our Board of Directors ... OXFORD, United Kingdom, Oct. 06, 2016 (GLOBE NEWSWIRE) -- Summit Therapeutics plc (AIM:SUMM) (NASDAQ:SMMT), the drug discovery and development company advancing therapies for Duchenne muscular ...MENLO PARK, Calif., October 31, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that data for its novel, potential first-in-class investigational bispecific antibody, ivonescimab, will be presented at the 38th Annual Meeting of the Society for Immunotherapy of Cancer (SITC) in San Diego, CA.Simply Wall St. Insider Monkey. Find the latest Summit Therapeutics Inc. (SMMT) stock quote, history, news and other vital information to help you with your stock trading and investing. Aug 2, 2023 · Summit was founded in 2003 and our shares are listed on the Nasdaq Global Market (symbol ‘SMMT’). We are headquartered in Menlo Park, California , and we have additional offices in Oxford, UK ... The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit Therapeutics Third Quarter 2023 Earnings and Update Call.WebOxford, UK, and Cambridge, MA, US, 15 January 2020 - Summit Therapeutics (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces that it has received notification that on 14 ...Summit Therapeutics Inc. (NASDAQ:SMMT) Q3 2023 Earnings Call Transcript November 7, 2023 Operator: Good morning, and welcome to the Summit …Nov 16, 2023 · The public float for SMMT is 111.77M and currently, short sellers hold a 8.48% ratio of that float. The average trading volume of SMMT on November 16, 2023 was 972.70K shares. SMMT) stock’s latest price update. The stock of Summit Therapeutics Inc (NASDAQ: SMMT) has increased by 0.51 when compared to last closing price of 1.97.

Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research ...WebNasdaq | SMMT U.S.: Nasdaq Summit Therapeutics Inc. Watch NEW Set a price target alert Premarket Last Updated: Nov 27, 2023 6:38 a.m. EST Delayed quote $ 2.0600 0.06 3.00% Before Hours...SMMT Latest Real Time Trades ... Add symbols now or see the quotes that matter to you, anywhere on Nasdaq.com. Start browsing stocks, funds and ETFs, and more asset classes. / Interactive Chart for Summit Therapeutics Inc. (SMMT), analyze all the data with a huge range of indicators.Instagram:https://instagram. best wealth managementis now a good time to invest in bondsstaples stocksapo ticker Summit Therapeutics Inc. Common Stock (SMMT) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Bitdeer Technologies Holding Co (NASDAQ:BTDR)’s Major holders Insiders own 59.14% of the company shares, while shares held by institutions stand at 2.18% with a share float percentage of 5.33%. Investors are also buoyed by the number of investors in a company, with Bitdeer Technologies Holding Co having a total of 13 institutions that hold ... apps like robin hoodhumana healthcare reviews Summit Therapeutics Inc. (NASDAQ:SMMT) Q1 2023 Earnings Call Transcript 11 Stocks with Heavy Insider Buying in 2023 Summit Therapeutics Inc. (NASDAQ:SMMT) Q4 2022 Earnings Call Transcript 25 ... can i trade after hours on robinhood MENLO PARK, Calif., January 30, 2023--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit" or the "Company") today announced that the Company’s Board of Directors has set the record date for the ...WebOxford, UK, and Cambridge, MA, US, 6 December 2019 - Summit Therapeutics plc (AIM: SUMM, NASDAQ: SMMT), a leader in antibiotic innovation, announces a proposed fundraising (the “Fundraising ...In the last year, multiple insiders have substantially increased their holdings of Summit Therapeutics Inc. (NASDAQ:SMMT) stock, indicating that insiders' optimism about the company's prospects ...